Agenus Inc (AGEN)
$3.27 -$0.05 (-1.49%) 4:38 PM 12/11/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$84.53M -
Day's Range
$3.27 - $3.44 -
Volume
596,561 -
52 Week Low / High
$2.50 - $19.69 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 1
- Strong Buy
- 0
- Buy
- 4
- Hold
- 0
- Sell
- 0
- Strong Sell
- $7.50
- Target Price
Company News
-
GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults — Sep 18th, 2024
GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults Wednesday, GSK plc (NYSE:GSK) released topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, reactogenicity and safety o...
-
GSK Announces Positive Topline Data on Co-Administration of AREXVY and SHINGRIX — Sep 18th, 2024
Trial met primary endpoint, non-inferior immune response for both vaccines when co-administered compared with separate administration Co-administration of the RSV and shingles adjuvanted vaccines was well tolerated, with acceptable reactogenicity and safety profiles These data advance the ...
Portfolio
Comprised of 1 portfolios